Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

作者: Maria I Leite , Margaret Jones , Philipp Ströbel , Alexander Marx , Ralf Gold

DOI: 10.2353/AJPATH.2007.070240

关键词:

摘要: In early-onset myasthenia gravis, the thymus contains lymph node-type infiltrates with frequent acetylcholine receptor (AChR)-specific germinal centers. Our recent evidence/two-step hypothesis implicates hyperplastic medullary thymic epithelial cells (expressing isolated AChR subunits) in provoking infiltration and myoid (with intact AChR) center formation. To test this, we screened for complement attack a wide range of typical generalized patients. Regardless exact serology, thymi sizeable unexpectedly showed patchy up-regulation both C5a terminal regulator CD59 on cells. These latter also deposits activated C3b component, which appeared even heavier infiltrating B cells, macrophages, especially follicular dendritic Myoid particularly vulnerable to complement; few expressed early regulators CD55, CD46, or CR1, none were detectably CD59+. Indeed, when exposed infiltrates, centers, frequently labeled C1q, (25 48%), C9, some showing obvious damage. This early/persistent strongly supports our hypothesis, implicating formation/autoantibody diversification. Remarkably, similar changes place many apparent AChR-seronegative patients same spectrum as AChR-seropositive

参考文章(59)
Catherine S. Davies, Claire L. Harris, B. Paul Morgan, Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects Immunology. ,vol. 114, pp. 280- 286 ,(2005) , 10.1111/J.1365-2567.2004.02086.X
Julian R. Pratt, Shamim A. Basheer, Steven H. Sacks, Local synthesis of complement component C3 regulates acute renal transplant rejection. Nature Medicine. ,vol. 8, pp. 582- 587 ,(2002) , 10.1038/NM0602-582
Matthew Fosbrink, Florin Niculescu, Violeta Rus, Moon L. Shin, Horea Rus, C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1 Journal of Biological Chemistry. ,vol. 281, pp. 19009- 19018 ,(2006) , 10.1074/JBC.M602055200
D. B. Sanders, K. El-Salem, J. M. Massey, J. McConville, A. Vincent, Clinical aspects of MuSK antibody positive seronegative MG Neurology. ,vol. 60, pp. 1978- 1980 ,(2003) , 10.1212/01.WNL.0000065882.63904.53
Amel Meraouna, Geraldine Cizeron-Clairac, Rozen Le Panse, Jacky Bismuth, Frederique Truffault, Chantal Tallaksen, Sonia Berrih-Aknin, The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis Blood. ,vol. 108, pp. 432- 440 ,(2006) , 10.1182/BLOOD-2005-06-2383
BENJAMIN CASTLEMAN, EDGAR H. NORRIS, The pathology of the thymus in myasthenia gravis; a study of 35 cases. Medicine. ,vol. 28, pp. 27- 58 ,(1949) , 10.1097/00005792-194902000-00002
Jean-Marc Navenot, Marcello Villanova, Brigitte Lucas-H�ron, Alessandro Malandrini, Dominique Blanchard, Jean-Pierre Louboutin, Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers Muscle & Nerve. ,vol. 20, pp. 92- 96 ,(1997) , 10.1002/(SICI)1097-4598(199701)20:1<92::AID-MUS12>3.0.CO;2-3
Myriam Schluep, Nicholas Willcox, Angela Vincent, Gurtej K. Dhoot, John Newsom-Davis, Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study Annals of Neurology. ,vol. 22, pp. 212- 222 ,(1987) , 10.1002/ANA.410220205
B. P. Morgan, J. Chamberlain-Banoub, J. W. Neal, W. Song, M. Mizuno, C. L. Harris, The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice. Clinical and Experimental Immunology. ,vol. 146, pp. 294- 302 ,(2006) , 10.1111/J.1365-2249.2006.03205.X